PASCAGOULA, Miss., June 13, 2022 (GLOBE NEWSWIRE) — All-domain defense and technologies partner HII (NYSE:HII) announced today the successful demonstration of capabilities enabling HII-built amphibious warships to launch, operate with and recover HII-built large-diameter unmanned underwater vehicles (LDUUV).
Oramed Granted Key European Patent For Platform Technology In Oral Delivery Of Proteins
- Protease inhibitor is a key component of Oramed's PODTM technology that protects therapeutic proteins in the digestive system
- Oramed has already been granted this patent in the United States and Japan
NEW YORK,